List of works - Mamta Ruparel

Decision Support Tools for Low-Dose CT Lung Cancer Screening

scientific article published in 2022

Defining the information needs of lung cancer screening participants: a qualitative study

scientific article published on 24 November 2019

Delivering low-dose CT screening for lung cancer: a pragmatic approach

scientific article published on 13 August 2020

Evaluation of cardiovascular risk in a lung cancer screening cohort

scientific article published on 26 September 2019

Fulfilling the Dream. Toward Reducing Inequalities in Lung Cancer Screening

scientific article published in July 2015

Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial

scientific article published on 01 June 2019

Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials

scientific article published on 11 December 2019

Lung Screen Uptake Trial: results from a single lung cancer screening round

scientific article published on 05 August 2020

Prevalence, Symptom Burden and Under-Diagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort

scientific article published on 13 March 2020

Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT)

scientific article published on 21 October 2020

Pulmonary nodules and CT screening: the past, present and future

scientific article

Reply to: Improving Lung Cancer Screening Uptake

scientific article published on 11 June 2020

Reply: Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening

scientific article published on December 2015

Smokers' interest in a lung cancer screening programme: a national survey in England. ⬇️

scientific article published on 2 May 2018

The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients ⬇️